Edition:
United States

Molecular Medicine SpA (MLMD.MI)

MLMD.MI on Milan Stock Exchange

0.46EUR
15 Dec 2017
Change (% chg)

€-0.01 (-1.67%)
Prev Close
€0.47
Open
€0.47
Day's High
€0.48
Day's Low
€0.46
Volume
7,819,835
Avg. Vol
4,288,811
52-wk High
€0.54
52-wk Low
€0.40

Revenue & Earnings Per Share

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 198.20 35.91
P/E High - Last 5 Yrs. -- 280.37 45.35
P/E Low - Last 5 Yrs. -- 93.75 24.23
Beta 0.98 0.82 0.91
Price to Sales (TTM) 9.55 122.78 5.95
Price to Book (MRQ) -- 23.45 5.68
Price to Tangible Book (MRQ) -- 27.39 7.29
Price to Cash Flow (TTM) -- 108.78 24.49
% Owned Institutions -- 5.61 1.41

Dividends

  Company industry sector
Dividend Yield -- 0.28 1.49
Dividend Yield - 5 Year Avg -- 0.26 2.05
Dividend 5 Year Growth Rate -- 1.99 5.25
Payout Ratio(TTM) -- 96.58 46.14

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 70.19 -5.04 6.79
Sales (TTM) vs TTM 1 Yr. Ago 39.74 29.98 5.62
Sales - 5 Yr. Growth Rate 41.64 33.48 10.24
EPS (MRQ) vs Qtr. 1 Yr. Ago 73.80 -150.15 7.85
EPS (TTM) vs TTM 1 Yr. Ago 59.51 -- --
EPS - 5 Yr. Growth Rate -- 44.93 10.94
Capital Spending - 5 Yr. Growth Rate 50.16 41.51 15.17

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.79 2.55
Current Ratio (MRQ) -- 5.62 3.56
LT Debt to Equity (MRQ) -- 16.22 13.38
Total Debt to Equity (MRQ) -- 18.71 19.38
Interest Coverage (TTM) -216.52 -139.32 44.30

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 78.19 44.18 54.91
Gross Margin - 5 Yr. Avg. 69.82 55.78 52.46
EBITD Margin (TTM) -25.89 -- --
EBITD - 5 Yr. Avg -152.49 -215.66 15.63
Operating Margin (TTM) -33.25 -642.63 6.56
Operating Margin - 5 Yr. Avg. -159.18 -232.87 11.00
Pre-Tax Margin (TTM) -34.71 -611.04 7.41
Pre-Tax Margin - 5 Yr. Avg. -160.59 -233.04 11.41
Net Profit Margin (TTM) -34.71 -608.78 3.64
Net Profit Margin - 5 Yr. Avg. -160.59 -236.43 7.70
Effective Tax Rate (TTM) -- 15.53 24.28
Effective Tax Rate - 5 Yr. Avg. -- 19.13 24.07

Efficiency

  Company industry sector
Revenue/Employee (TTM) 130,665 22,314,532 851,801,741
Net Income/Employee (TTM) -45,359 -1,997,855 99,542,701
Receivable Turnover (TTM) -- 26.15 6.13
Inventory Turnover (TTM) -- 2.62 3.56
Asset Turnover (TTM) -- 0.42 0.96

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- -9.39 11.31
Return on Assets - 5 Yr. Avg. -44.28 0.28 12.28
Return on Investment (TTM) -- -11.76 14.43
Return on Investment - 5 Yr. Avg. -66.81 3.42 16.07
Return on Equity (TTM) -- -36.72 16.01
Return on Equity - 5 Yr. Avg. -79.18 5.75 17.27
  1 Year 3 Year 5 Year
Sales % 43.52 49.29 41.64
EPS (TTM) % 41.84 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Molecular Medicine SpA

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 4.01 3.79 99 94
13 Week 4.90 5.19 99 75
26 Week 11.66 5.95 99 59
52 Week 4.83 -11.44 99 58
YTD 11.15 -4.71 99 51
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 1.83%
# of Holders: 10
Total Shares Held: 8,351,574
3 Mo. Net Change: 1,603,237
# New Positions: 1
# Closed Positions: 1
# Increased Positions: 3
# Reduced Positions: 1
# Net Buyers: 2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.